← Open Payments lookup

JUAN OMS: Open Payments

NPI 1508067679 · MIAMI, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,856 in 90 payments from 14 companies in 2025. Trend: 2023 $2,305 · 2024 $3,177 · 2025 $2,856

Food & beverage: $2,856
CompanyPaymentsAmount
Teva Pharmaceuticals USA, Inc.13$535
E.R. Squibb & Sons, L.L.C.13$406
Neurocrine BioSciences, Inc.5$312
Alkermes, Inc.13$296
Indivior Inc.9$296
Otsuka America Pharmaceutical, Inc.5$220
Janssen Pharmaceuticals, Inc8$179
Luye Pharma (USA) Ltd.3$159
Vanda Pharmaceuticals Inc.6$150
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)7$127

Products named: UZEDY, COBENFY, INGREZZA, SUBLOCADE, VIVITROL, REXULTI, INVEGA SUSTENNA, ERZOFRI EXTENDED-RELEASE.

Industry payments across FL — which companies pay providers there.